| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $48.2M | +63.7% |
| SG&A Expense | $11.9M | -10.8% |
| Operating Income | -$60.1M | -40.5% |
| Income Tax | $1K | — |
| Net Income | -$55.9M | -48.8% |
| EPS (Basic) | -$0.94 | -46.9% |
| EPS (Diluted) | -$0.94 | -46.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $54.5M | — |
| Short-term Investments | $46.6M | — |
| Current Assets | $104.1M | -29.6% |
| Total Assets | $104.6M | -29.5% |
| Current Liabilities | $18.6M | -16.4% |
| Long-term Debt | $15.3M | +0.0% |
| Total Liabilities | $33.6M | +17.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.2M | -42.5% |
| Investing Cash Flow | -$44.9M | -249.7% |
| Financing Cash Flow | -$171K | +86.5% |
| Stockholders' Equity |
| $71.0M |
| -40.7% |